Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorinda Simms

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Biostatistics primer: what a clinician ought to know: hazard ratiosHelen Barraclough, Lorinda Simms, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
In responseHelen Barraclough, Lorinda Simms, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2013
Biostatistics primer: what a clinician ought to know--prognostic and predictive factorsLorinda Simms, Helen Barraclough, Ramaswamy Govindan
The Cochrane Database of Systematic Reviews|February 13, 2015
WITHDRAWN: Anti-tuberculous therapy for maintenance of remission in Crohn's diseaseMark Borgaonkar, Don MacIntosh, John Fardy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008
The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature reviewFred R Hirsch, Anna Spreafico, Silvia Novello, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2010
Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trialChih-Hsin Yang, Lorinda Simms, Keunchil Park, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 5, 2002
A randomized survey of the preference of gastroenterologists for a Cochrane review versus a traditional narrative reviewJohn W D McDonald, Jeffrey Mahon, Kelly Zarnke, et al.
The Oncologist|February 18, 2009
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studiesGiorgio Scagliotti, Nasser Hanna, Frank Fossella, et al.
Investigational New Drugs|October 29, 2008
Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumorsAxel-R Hanauske, Herlinde Dumez, Martine Piccart, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 9, 2003
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pyloriSander Veldhuyzen van Zanten, Naoki Chiba, Alan Barkun, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Biostatistics primer: what a clinician ought to know: hazard ratiosHelen Barraclough, Lorinda Simms, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
In responseHelen Barraclough, Lorinda Simms, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2013
Biostatistics primer: what a clinician ought to know--prognostic and predictive factorsLorinda Simms, Helen Barraclough, Ramaswamy Govindan
The Cochrane Database of Systematic Reviews|February 13, 2015
WITHDRAWN: Anti-tuberculous therapy for maintenance of remission in Crohn's diseaseMark Borgaonkar, Don MacIntosh, John Fardy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008
The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature reviewFred R Hirsch, Anna Spreafico, Silvia Novello, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2010
Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trialChih-Hsin Yang, Lorinda Simms, Keunchil Park, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 5, 2002
A randomized survey of the preference of gastroenterologists for a Cochrane review versus a traditional narrative reviewJohn W D McDonald, Jeffrey Mahon, Kelly Zarnke, et al.
The Oncologist|February 18, 2009
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studiesGiorgio Scagliotti, Nasser Hanna, Frank Fossella, et al.
Investigational New Drugs|October 29, 2008
Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumorsAxel-R Hanauske, Herlinde Dumez, Martine Piccart, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 9, 2003
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pyloriSander Veldhuyzen van Zanten, Naoki Chiba, Alan Barkun, et al.
Pageof 3